Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,702 total articles
Accenture's recent beat highlights strong AI demand, but guidance of 3-6% revenue growth and a market cap of ~$128B imply the company must deliver flawless execution and sustained margin expansion. We lay out a short trade that profits if the market re-rates expectations as pricing pressure, acquisition integration, and productization of AI service…
SCHD is a high-quality, low-cost dividend ETF trading at $33.04 with a 3.31% yield and $110.3B implied market cap. The fund's dividend-only value proposition is being challenged by funds that target both dividends and buybacks. This trade idea recommends a controlled short of SCHD (entry $33.04, stop $34.00, target $29.00) over a mid-term 45 tradin…
Pitney Bowes is generating outsized free cash flow relative to its market cap, giving the stock a low P/FCF and compelling risk-reward. We like a long trade targeting a re-rating toward mid-teens earnings multiples, while protecting capital with a tight stop below recent support.
Bandwidth is trading on a reasonable EV/S of 2.3 with improving free cash flow and clear AI-led use cases in communications. Technicals look mixed, but Q3 is a catalyst that can re-accelerate revenue and drive multiple expansion. This trade targets a mid-term gain while protecting capital against a guidance miss or competitive pressure.
Zeta Global reported another beat-and-raise quarter with revenue growth north of 40% and improving unit economics. The stock has already rallied, but the combination of a large revenue glidepath, growing 'super-scaled' AI customers, and $214M in free cash flow supports further upside. This is a long-term trade with a clear entry at $33.00, stop at …
Rivian's R2 SUV is gaining real traction — Q3 deliveries jumped to 19,248 units and management secured a $1B fixed-rate loan from Volkswagen that eases financing fears. Execution on R2 and a path to automotive gross-margin improvement are catalysts for a tactical long. We upgrade the rating and lay out an actionable trade with entry, target and sto…
Lumentum (LITE) sits in the eye of the AI optics boom. Demand for high-speed transceivers and photonic subsystems has driven double-digit revenue growth and a market cap near $100B, and the stock is pricing multi-year scarcity into its valuation. This trade idea buys the growth narrative while protecting against a sharp multiple reset. Entry $1107.…
Permian Resources (PR) is a capital-efficient Permian Basin E&P trading at a reasonable multiple relative to its cash flow and with a modest dividend. We like a disciplined long entry on a near-term dip for a mid-term (45 trading days) swing, size appropriately, and use a clear stop to respect oil-price risk.
Happen, Inc. (HAPN) looks actionable near $15.18: cheap valuation (roughly 9x P/E, 1.1x book), constructive momentum indicators, and a defined support band near the 52-week low. This trade plan targets $19.00 with a stop at $13.05 over a mid-term horizon (45 trading days). Risk/reward is asymmetric if credit conditions remain stable and loan-sale e…
Pampa Energía (PAM) offers a rare combination of low valuation, diversified cash-generating assets and recent insider buying. At roughly $80, the stock trades at a P/E of 7.5 and a P/B of 1.07 — a price that, in our view, understates improving oil & gas production and the company's integrated power footprint. We outline a concrete long trade with e…
Krystal Biotech has moved beyond proof-of-concept into a commercial-phase growth story. Recent quarterly results, solid free cash flow and a clear regulatory footprint in the U.S., Europe and Japan suggest the market is underpricing continued revenue expansion and pipeline optionality. I present a long trade with precise entry, stop and target alig…
Carlsberg shares trade near the low end of their 52-week range while the company shows stable cash generation, a 2.28% yield and a reasonable P/E of 17.3. Ongoing beer-volume weakness keeps sentiment negative, but improving technicals, research-driven product optionality and a modest valuation discount make a mid-term long trade attractive. Entry $…
Credo (CRDO) is riding retimer demand and rising ASPs into strong top-line growth, but it's priced for perfection. This trade idea proposes a measured long at $216.55 with a $290 target and a $186 stop, a mid-term (45 trading days) swing that leans on product momentum, cash-flow improvements, and short-interest dynamics while respecting valuation a…
I’m upgrading Marvell (MRVL) to Buy. The stock is no longer a pure growth story priced for perfection; it has real revenue acceleration, improving margins and partnerships that make the premium plausible. Trade plan: enter at $275.33, stop $235.00, target $420.00 for a long-term (180 trading days) hold — size it for volatility and watch upcoming gu…
ERock's current market cap of roughly $2.62B already reflects a sizeable premium for future installed base and service revenue tied to a $1.3B backlog and planned manufacturing expansion. Short interest and recent weakness create a tactical buying window. This trade banks on service economics and backlog conversion over the next 45 trading days, wi…
5E Advanced Materials (FEAM) has moved from pilot production into commercial qualification with a 7,500 tpy long-term offtake and a proprietary higher-B2O3 boric acid. Backed by a $36M oversubscribed raise and active product trials, FEAM looks set for a re-rating if execution and financing milestones hold. This is a mid-term trade idea with clear e…
Amazon looks attractively positioned as AWS demand from AI and cloud modernization accelerates. With a $2.83 trillion market cap, a P/E near 21, healthy ROE, and a recent long-term power deal to underwrite data-center expansion, the risk/reward skews to the upside. I recommend a strong buy with a clear entry, stop and $310 target over a 180-trading…
Microsoft's AI-driven revenue cadence is moving from investment to monetization. With a $3.97T market cap, 2026 EPS around $18.01 and FCF of $66.99B, the company has the balance-sheet stamina to convert higher-margin AI products into durable earnings. Technicals show bullish momentum, but valuation is rich and execution risks persist. Trade plan: e…
Brazil Potash (GRO) is showing the ingredients that can move a development-stage miner from speculative to fundable: high offtake coverage, meaningful recent equity proceeds, an advisor to source construction capital, and a contract that removes tens of millions of upfront capex. The chart is beaten down but not broken. This trade idea lays out a m…
Entrada Therapeutics cratered after a modest dystrophin readout, but the stock now trades at $5.67 with a market cap of $221M, cash runway into Q3 2027, and a Data Monitoring Committee that has green-lit a higher dose for its exon-45 program. For traders willing to accept clinical and financing risk, this is an actionable long with a tight stop and…
Alphamin Resources (AFMJF) is an OTC-listed resource company trading at $1.03 with improving technicals, rising volume and elevated short activity. This trade idea frames a disciplined long while acknowledging operational and market-level uncertainty typical of OTC names. Entry, stop and target levels are concrete and time-bound.
EQT offers an attractive free cash flow yield (roughly 11%-12%), healthy leverage metrics, and near-term demand support from LNG contracts and rising power-sector gas use tied to data center growth. This trade idea lays out an actionable entry, stop, and target with a mid-term horizon and balanced risk framing.
Bilibili has quietly moved from loss-making to consistent profit across 2025. Revenues are growing, margins are improving and management has lined up capital (convertible notes + buybacks) to accelerate AI-driven monetization and share repurchases. At a $6.44B market cap and a stock trading near its 52-week low, the market is underestimating the du…
Glaukos (GKOS) is trading near $165.70 after a licensing deal that expands its retinal pipeline and renewed optimism around its specialty ophthalmology franchises. Market cap is roughly $9.77B and shares have rallied from a 52-week low of $73.16 to a high of $191.62. We outline a mid-term (45 trading days) trade: enter at $165.70, target $190.00, s…
Fabrinet is a pure-play optical packaging and precision manufacturing partner for the AI datacenter buildout. Recent results show DCI (data center interconnect) revenues accelerating to over half of sales and a >$1B annualized run rate. The stock trades at reasonable revenue multiples for a high-growth supplier, but weak free cash flow and short-te…
